Introduction to Clinical Cases: Toripalimab in Recurrent and Metastatic NPC

An expert discusses the use of toripalimab in the treatment of recurrent and metastatic nasopharyngeal carcinoma (NPC) through clinical case introductions.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Now Viewing

EP: 1.Introduction to Clinical Cases: Toripalimab in Recurrent and Metastatic NPC

EP: 2.Considerations for NPC Therapy: Clinical Perspectives From Radiation Oncology

EP: 3.Targeting Recurrent and Metastatic NPC With Systemic Immunotherapy: The Role of Toripalimab and Insights From Radiation Oncology

EP: 4.Monitoring Treatment Response in NPC: Looking to EBV Titers and Imaging

EP: 5.Evolving Paradigms: The Role of Systemic Immunotherapy in NPC Treatment

Recent Videos

Personalized JAK Inhibitor Selection in Myelofibrosis: Clinical Characteristics, Molecular Profiles, and Treatment Sequencing

Advancing Treatment Paradigms in Myeloproliferative Neoplasms: From Molecular Pathogenesis to Patient-Tailored Therapy

Diagnostic Challenges in Myelofibrosis: Distinguishing Prefibrotic Disease_

The Evolving Landscape of Myelofibrosis: Current Understanding and Clinical Patterns

Insights from COCOON: Prophylactic Dermatologic Management With Amivantamab + Lazertinib in Advanced NSCLC

1L Treatment for Advanced NSCLC

Recap: ELCC 2025 Highlights

Presented at ELCC 2025: Key Takeaways From KRYSTAL-7

ELCC 2025: Insights From the MARIPOSA Study

LAURA Study: NGS Testing in Diagnosis of NSCLC